Design of High-affinity Major Histocompatibility Complex-specific Antagonist Peptides That Inhibit Cytotoxic T-lymphocyte Activity: Implications for Control of Viral Disease

Overview

Journal J Virol

Publisher American Society for Microbiology

Date 1992 Nov 1

PMID 1383569

Citations 16

Authors

J E Gairin

M B Oldstone

Affiliations

Soon will be listed here.

Abstract

Cytotoxic T lymphocytes (CTLs) recognize viral antigens presented by infected cells in the context of their major histocompatibility complex glycoproteins. The irreversible killing of virus-infected cells by virus-specific CTLs can be the cause of serious disease, particularly in the central nervous, hepatic, and cardiovascular systems. Design of molecules controlling (blocking) interaction between CTLs and infected cells, and their further use to inhibit (or antagonize) T-lymphocyte activity, is an important pharmacologic goal. In this report, we describe the design of a new family of peptides which selectively inhibit activity of lymphocytic choriomeningitis virus-specific CD8+ T lymphocytes, which recognize endogenously processed viral epitopes presented by major histocompatibility complex class I molecules.

Citing Articles

Diversity of escape variant mutations in Simian virus 40 large tumor antigen (SV40 Tag) epitopes selected by cytotoxic T lymphocyte (CTL) clones.

Mylin L, Schell T, Epler M, Kusuma C, Assis D, Matsko C Virology. 2007; 364(1):155-68.

PMID: 17368499 PMC: 3866617. DOI: 10.1016/j.virol.2007.02.007.

Antagonistic variant virus prevents wild-type virus-induced lethal immunopathology.

Hunziker L, Recher M, Ciurea A, Martinic M, Odermatt B, Hengartner H J Exp Med. 2002; 196(8):1039-46.

PMID: 12391015 PMC: 2194044. DOI: 10.1084/jem.20012045.

Quantitation of CD8(+) T-lymphocyte responses to multiple epitopes from simian virus 40 (SV40) large T antigen in C57BL/6 mice immunized with SV40, SV40 T-antigen-transformed cells, or vaccinia virus recombinants expressing full-length T antigen or....

Mylin L, Schell T, Roberts D, Epler M, Boesteanu A, Collins E J Virol. 2000; 74(15):6922-34.

PMID: 10888631 PMC: 112209. DOI: 10.1128/jvi.74.15.6922-6934.2000.

Cytotoxic T-lymphocyte epitope immunodominance in the control of choroid plexus tumors in simian virus 40 large T antigen transgenic mice.

Schell T, Mylin L, Georgoff I, Teresky A, Levine A, Tevethia S J Virol. 1999; 73(7):5981-93.

PMID: 10364350 PMC: 112659. DOI: 10.1128/JVI.73.7.5981-5993.1999.

Molecular mimicry and immune-mediated diseases.

Oldstone M FASEB J. 1998; 12(13):1255-65.

PMID: 9761770 PMC: 7164021. DOI: 10.1096/fasebj.12.13.1255.

References

Deckhut A, Lippolis J, Tevethia S . Comparative analysis of core amino acid residues of H-2D(b)-restricted cytotoxic T-lymphocyte recognition epitopes in simian virus 40 T antigen. J Virol. 1992; 66(1):440-7. PMC: 238304. DOI: 10.1128/JVI.66.1.440-447.1992. View

Hammerling G, Rusch E, Tada N, Kimura S, Hammerling U . Localization of allodeterminants on H-2Kb antigens determined with monoclonal antibodies and H-2 mutant mice. Proc Natl Acad Sci U S A. 1982; 79(15):4737-41. PMC: 346752. DOI: 10.1073/pnas.79.15.4737. View

Falk K, Rotzschke O, Stevanovic S, Jung G, Rammensee H . Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature. 1991; 351(6324):290-6. DOI: 10.1038/351290a0. View

Oldstone M . Molecular anatomy of viral persistence. J Virol. 1991; 65(12):6381-6. PMC: 250674. DOI: 10.1128/JVI.65.12.6381-6386.1991. View

De Magistris M, Alexander J, Coggeshall M, Altman A, Gaeta F, Grey H . Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor. Cell. 1992; 68(4):625-34. DOI: 10.1016/0092-8674(92)90139-4. View

Nepom G, Erlich H . MHC class-II molecules and autoimmunity. Annu Rev Immunol. 1991; 9:493-525. DOI: 10.1146/annurev.iy.09.040191.002425. View

Lamont A, Sette A, Grey H . Inhibition of antigen presentation in vitro and in vivo by MHC antagonist peptides. Int Rev Immunol. 1990; 6(1):49-59. DOI: 10.3109/08830189009056617. View

Ljunggren H, Stam N, Ohlen C, Neefjes J, Hoglund P, Heemels M . Empty MHC class I molecules come out in the cold. Nature. 1990; 346(6283):476-80. DOI: 10.1038/346476a0. View

Maryanski J, Verdini A, Weber P, Salemme F, Corradin G . Competitor analogs for defined T cell antigens: peptides incorporating a putative binding motif and polyproline or polyglycine spacers. Cell. 1990; 60(1):63-72. DOI: 10.1016/0092-8674(90)90716-r. View

10.

Adorini L, Nagy Z . Peptide competition for antigen presentation. Immunol Today. 1990; 11(1):21-4. DOI: 10.1016/0167-5699(90)90006-u. View

11.

Pala P, BODMER H, Pemberton R, Cerottini J, Maryanski J, Askonas B . Competition between unrelated peptides recognized by H-2-Kd restricted T cells. J Immunol. 1988; 141(7):2289-94. View

12.

Townsend A, Bodmer H . Antigen recognition by class I-restricted T lymphocytes. Annu Rev Immunol. 1989; 7:601-24. DOI: 10.1146/annurev.iy.07.040189.003125. View

13.

Schulz M, Aichele P, Vollenweider M, Bobe F, Cardinaux F, Hengartner H . Major histocompatibility complex--dependent T cell epitopes of lymphocytic choriomeningitis virus nucleoprotein and their protective capacity against viral disease. Eur J Immunol. 1989; 19(9):1657-67. DOI: 10.1002/eji.1830190921. View

14.

Guillet J, Lai M, Briner T, Smith J, Gefter M . Interaction of peptide antigens and class II major histocompatibility complex antigens. Nature. 1986; 324(6094):260-2. DOI: 10.1038/324260a0. View

15.

Todd J, Acha-Orbea H, Bell J, Chao N, Fronek Z, Jacob C . A molecular basis for MHC class II--associated autoimmunity. Science. 1988; 240(4855):1003-9. DOI: 10.1126/science.3368786. View

16.

Cole G, NATHANSON N, PRENDERGAST R . Requirement for theta-bearing cells in lymphocytic choriomeningitis virus-induced central nervous system disease. Nature. 1972; 238(5363):335-7. DOI: 10.1038/238335a0. View

17.

Ozato K, Hansen T, Sachs D . Monoclonal antibodies to mouse MHC antigens. II. Antibodies to the H-2Ld antigen, the products of a third polymorphic locus of the mouse major histocompatibility complex. J Immunol. 1980; 125(6):2473-7. View

18.

Oldstone M, Tishon A, Geckeler R, Lewicki H, Whitton J . A common antiviral cytotoxic T-lymphocyte epitope for diverse major histocompatibility complex haplotypes: implications for vaccination. Proc Natl Acad Sci U S A. 1992; 89(7):2752-5. PMC: 48740. DOI: 10.1073/pnas.89.7.2752. View

19.

Tevethia S, Lewis M, Tanaka Y, Milici J, Knowles B, Maloy W . Dissection of H-2Db-restricted cytotoxic T-lymphocyte epitopes on simian virus 40 T antigen by the use of synthetic peptides and H-2Dbm mutants. J Virol. 1990; 64(3):1192-200. PMC: 249233. DOI: 10.1128/JVI.64.3.1192-1200.1990. View

20.

Lamont A, Sette A, Fujinami R, Colon S, Miles C, Grey H . Inhibition of experimental autoimmune encephalomyelitis induction in SJL/J mice by using a peptide with high affinity for IAs molecules. J Immunol. 1990; 145(6):1687-93. View